FeesSafety
Pluang+

Tron Inc. buys $50K more TRX, pushing holdings above 720.5M tokens amid price recovery attempts.

Protocol Fundamentals
26 Oct 2026, 21:55 WIB
AMBCrypto
View Source
Neutral
Tron Inc. buys $50K more TRX, pushing holdings above 720.5M tokens amid price recovery attempts.

Tron Inc. purchased an additional 150,997 TRX tokens on October 26, spending about $50,000 and raising its total holdings to over 720.5 million TRX. This purchase is part of a daily buying plan announced earlier this year to acquire roughly $50,000 worth of TRX each day for 360 days. Despite these ongoing acquisitions, TRX's price has only seen modest recovery from its recent decline, currently trading near $0.331. The next key resistance levels to watch are around $0.332–$0.333 and $0.335–$0.337, which could influence further price movements.

TRX crypto holdings and price context are provided here as of Oct 27, 2026 01:51 WIB. For readers following major cryptocurrencies, Pluang data shows 17 of 50 priced assets rose while 31 fell today. Notable movers include CAKE at Rp38.790 with a 1-day change of +4.72% and a Pluang order activity split of 35% Sell / 65% Buy, GRT at Rp399 down 3.53% with 13% Sell / 87% Buy, and ZIL at Rp36 up 3.12% with 58% Sell / 42% Buy. The most notable figure is CAKE's 4.72% gain in one day.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
35 minutes ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
35 minutes ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
47 minutes ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
2 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App